Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun pharmacology One of the class of drugs used on the
digestive system , including all drugs whose primary effect is to augment the speed of intestinal transit, by increasing the frequency of contractions in thesmall intestine or making them stronger, but without disrupting their rhythm.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word prokinetic.
Examples
-
Tranzyme Pharma today announced that the United States Adopted Name Council (USAN) has approved the generic name "ulimorelin" for Tranzyme's novel, late-stage, prokinetic agent TZP-101.
THE MEDICAL NEWS 2010
-
ARYx currently has four products in clinical development: an oral anti-arrhythmic agent for the treatment of atrial fibrillation, budiodarone (ATI-2042); an oral anticoagulant agent for patients at risk for the formation of dangerous blood clots, tecarfarin (ATI-5923); a prokinetic agent for the treatment of various gastrointestinal disorders, ATI-7505; and, an agent for the treatment of schizophrenia and other psychiatric disorders, ATI-9242.
Automotive Headlines dse@theautochannel.com 2010
-
ARYx currently has four products in clinical development: an oral anti-arrhythmic agent for the treatment of atrial fibrillation, budiodarone (ATI-2042); an oral anticoagulant agent for patients at risk for the formation of dangerous blood clots, tecarfarin (ATI-5923); a prokinetic agent for the treatment of various gastrointestinal disorders, ATI-7505; and, an agent for the treatment of schizophrenia and other psychiatric disorders, ATI-9242.
-
To date, ulimorelin has been successfully studied in two international Phase 2 trials, one for the management of postoperative ileus (POI) and a second for the treatment of acute gastroparesis, and has the potential to treat other conditions where a safe and effective GI prokinetic therapy is desired in acute care settings.
THE MEDICAL NEWS 2010
-
ARYx currently has four products in clinical development: a prokinetic agent for the treatment of various gastrointestinal disorders, naronapride (ATI-7505); an oral anticoagulant agent for patients at risk for the formation of dangerous blood clots, tecarfarin (ATI-5923); an oral anti-arrhythmic agent for the treatment of atrial fibrillation, budiodarone (ATI-2042); and, an agent for the treatment of schizophrenia and other psychiatric disorders, ATI-9242.
ARYx Therapeutics Receives NASDAQ Notice of Non-Compliance - Yahoo! Finance 2010
-
ARYx currently has four products in clinical development: an oral anti-arrhythmic agent for the treatment of atrial fibrillation, budiodarone (ATI-2042); an oral anticoagulant agent for patients at risk for the formation of dangerous blood clots, tecarfarin (ATI-5923); a prokinetic agent for the treatment of various gastrointestinal disorders, ATI-7505; and, an agent for the treatment of schizophrenia and other psychiatric disorders, ATI-9242.
-
Because prokinetic penis enlargement pill viagra men disease is ribosomal and may drown unrecognized, it may soak datausual formally to induce iowa therapy atack even in eyedrops nondilated passively for hypertension.
Wii-volution 2010
-
ARYx currently has four products in clinical development: an oral anti-arrhythmic agent for the treatment of atrial fibrillation, budiodarone (ATI-2042); an oral anticoagulant agent for patients at risk for the formation of dangerous blood clots, tecarfarin (ATI-5923); a prokinetic agent for the treatment of various gastrointestinal disorders, ATI-7505; and, an agent for the treatment of schizophrenia and other psychiatric disorders, ATI-9242.
-
The safety and pharmacokinetic profiles of ulimorelin have been extensively characterized in healthy subjects and patients across multiple dose levels, and the GI prokinetic properties of the compound have been well established in humans.
THE MEDICAL NEWS 2010
-
ARYx currently has four products in clinical trials: an oral anticoagulant agent for patients at risk for the formation of dangerous blood clots, tecarfarin (previously ATI-5923); an oral anti-arrhythmic agent for the treatment of atrial fibrillation, budiodarone (previously ATI-2042); a prokinetic agent for the treatment of various gastrointestinal disorders, ATI-7505; and, an agent for the treatment of schizophrenia and other psychiatric disorders, ATI-9242.
unknown title 2009
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.